Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.840
Bid (Size) 4.700 (1)
Ask (Size) 4.850 (1)
Prev. Close 4.840
Today's Range 4.840 - 4.840
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across... 
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
News headline image
AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare
The pharmaceutical and biotechnology industries are undergoing a profound transformation, driven by an urgent need for more efficient drug discovery and development processes and the paradigm shift... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence

Performance

More News

Read More
News headline image
Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
Via MarketMinute
Topics Artificial Intelligence
News headline image
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Dawn of Hyper-Personalization: How Generative AI is Reshaping Our Digital World
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
NVIDIA Invested in These 2 AI Stocks, Should You?
Via MarketBeat
Topics Artificial Intelligence
News headline image
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
From Exscientia plc
Via Business Wire
News headline image
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
From Exscientia plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week ↗
Via Talk Markets
News headline image
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th ↗
Via Talk Markets
News headline image
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! ↗
Via Talk Markets
Topics Economy
News headline image
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Exscientia plc
Via Business Wire
News headline image
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week ↗
Via Talk Markets
News headline image
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. ↗
Via The Motley Fool
News headline image
EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
Exscientia Business Update for Second Quarter and First Half 2024
From Exscientia plc
Via Business Wire
News headline image
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD ↗
Via Talk Markets
News headline image
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
From FN Media Group LLC
Via GlobeNewswire
News headline image
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals ↗
Via Benzinga
Topics Artificial Intelligence

Frequently Asked Questions

Is Exscientia Plc - American Depositary Shares publicly traded?
Yes, Exscientia Plc - American Depositary Shares is publicly traded.
What exchange does Exscientia Plc - American Depositary Shares trade on?
Exscientia Plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Exscientia Plc - American Depositary Shares?
The ticker symbol for Exscientia Plc - American Depositary Shares is EXAI on the Nasdaq Stock Market
What is the current price of Exscientia Plc - American Depositary Shares?
The current price of Exscientia Plc - American Depositary Shares is 4.840
When was Exscientia Plc - American Depositary Shares last traded?
The last trade of Exscientia Plc - American Depositary Shares was at 11/19/24 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>